Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0?NLS, against Herpes Simplex Virus 1.

Noncognate Signals Drive Enhanced Effector CD8+ T Cell Responses through an IFNAR1-Dependent Pathway after Infection with the Prototypic Vaccine, 0?NLS, against Herpes Simplex Virus 1. J Virol. 2022 03 23; 96(6):e0172421.

View in: PubMed

subject areas

Animals
CD8-Positive T-Lymphocytes
Herpes Simplex
Herpes Simplex Virus Vaccines
Herpesvirus 1, Human
Interferon-gamma
Mice
Mice, Inbred C57BL
Receptor, Interferon alpha-beta

authors with profiles

Daniel J Carr